Abstract:Nicotinic acid adenine dinucleotide phosphate (NAADP) is a molecule capable of initiating the release of intracellular Ca2+ required for many essential cellular processes. Recent evidence links two-pore channels (TPCs) with NAADP-induced release of Ca2+ from lysosome-like acidic organelles; however, there has been no direct demonstration that TPCs can act as NAADP-sensitive Ca2+ release channels. Controversial evidence also proposes ryanodine receptors as the primary target of NAADP. We show that TPC2, the maj… Show more
“…NAADP-dependent currents in WT lysosomes displayed a bell-shaped dose-response relationship (Fig. 1d) as reported previously 25,26 .…”
Section: Loss Of Tpc2 Impairs Trafficking In the Degradation Pathwaysupporting
confidence: 59%
“…Independent of what the nature of the endogenous ligand of these channels might be, there is substantial evidence that on activation TPCs mediate the release of Ca 2 þ from lysosomal stores. Patch-clamp 21,22,24 , lipid bilayer and calcium imaging experiments 18,25,26 indicate that TPCs are Ca 2 þ permeable channels and, hence, may directly confer Ca 2 þ release from endosomes/lysosomes.…”
Endolysosomal organelles play a key role in trafficking, breakdown and receptor-mediated recycling of different macromolecules such as low-density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or transferrin. Here we examine the role of two-pore channel (TPC) 2, an endolysosomal cation channel, in these processes. Embryonic mouse fibroblasts and hepatocytes lacking TPC2 display a profound impairment of LDL-cholesterol and EGF/EGF-receptor trafficking. Mechanistically, both defects can be attributed to a dysfunction of the endolysosomal degradation pathway most likely on the level of late endosome to lysosome fusion. Importantly, endolysosomal acidification or lysosomal enzyme function are normal in TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic cholesterol overload and liver damage consistent with non-alcoholic fatty liver hepatitis. These findings indicate reduced metabolic reserve of hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial role in trafficking in the endolysosomal degradation pathway and, thus, is potentially involved in the homoeostatic control of many macromolecules and cell metabolites.
“…NAADP-dependent currents in WT lysosomes displayed a bell-shaped dose-response relationship (Fig. 1d) as reported previously 25,26 .…”
Section: Loss Of Tpc2 Impairs Trafficking In the Degradation Pathwaysupporting
confidence: 59%
“…Independent of what the nature of the endogenous ligand of these channels might be, there is substantial evidence that on activation TPCs mediate the release of Ca 2 þ from lysosomal stores. Patch-clamp 21,22,24 , lipid bilayer and calcium imaging experiments 18,25,26 indicate that TPCs are Ca 2 þ permeable channels and, hence, may directly confer Ca 2 þ release from endosomes/lysosomes.…”
Endolysosomal organelles play a key role in trafficking, breakdown and receptor-mediated recycling of different macromolecules such as low-density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or transferrin. Here we examine the role of two-pore channel (TPC) 2, an endolysosomal cation channel, in these processes. Embryonic mouse fibroblasts and hepatocytes lacking TPC2 display a profound impairment of LDL-cholesterol and EGF/EGF-receptor trafficking. Mechanistically, both defects can be attributed to a dysfunction of the endolysosomal degradation pathway most likely on the level of late endosome to lysosome fusion. Importantly, endolysosomal acidification or lysosomal enzyme function are normal in TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic cholesterol overload and liver damage consistent with non-alcoholic fatty liver hepatitis. These findings indicate reduced metabolic reserve of hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial role in trafficking in the endolysosomal degradation pathway and, thus, is potentially involved in the homoeostatic control of many macromolecules and cell metabolites.
“…The fact that NAADP-dependent Ca 2ϩ signaling is enhanced by the expression of hTPC1, hTPC2, and rTPC3, respectively, provides further support for the view that TPCs are of fundamental importance to this process (11), irrespective of the controversy surrounding their ability to conduct Ca 2ϩ (9,10,13). That hTPC1 was entirely restricted to different subpopulations of endosomes, hTPC2 to lysosomes, and rTPC3 to both endosomes and lysosomes provided us with the opportunity to further assess the capacity for organellar coupling to the ER by CICR.…”
Background:The role of two-pore channels (TPCs) in endolysosomal signaling remains controversial. Results: TPCs are targeted to different subpopulations of endolysosomes, and this determines subunit interaction and Ca
“…Consistent with this notion, IL-1 release was reduced significantly by 2-APB, U18666A, and NED-19, all of which disrupt the release or handling of intracellular calcium stores. U18666A and NED-19 specifically modulate acidic calcium stores (23,24). Similar to the lysosomal acidification inhibitors, these calcium-modulating compounds reduced the level of IL-1 mRNA.…”
Section: Discussionmentioning
confidence: 99%
“…8F). To further investigate the role of lysosomal calcium in this response, we took advantage of the compound NED-19, which selectively inhibits the NAADPactivated calcium channel that resides on the lysosome (24). NED-19-treated pMACs also secreted less IL-1 and produced less IL-1 mRNA compared with vehicle-treated cells, providing further evidence that lysosomal calcium contributes to lipotoxic inflammasome activation (Fig.…”
Section: Intracellular Calcium Stores Are Required For Il-1 Release mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.